O

OXVax Ltd

4 employees

OxVax focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Therapeutics

Date founded

2021

Funding rounds raised

O

OXVax Ltd raised undisclosed on April 21, 2021

Investors: Evotec

FAQ